Synlogic Inc (SYBX)
1.85
+0.01
(+0.54%)
USD |
NASDAQ |
Apr 23, 10:06
Synlogic Enterprise Value: -26.32M for April 22, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| April 22, 2024 | -26.32M |
| April 19, 2024 | -25.97M |
| April 18, 2024 | -26.43M |
| April 17, 2024 | -27.13M |
| April 16, 2024 | -26.78M |
| April 15, 2024 | -26.78M |
| April 12, 2024 | -27.13M |
| April 11, 2024 | -27.36M |
| April 10, 2024 | -26.55M |
| April 09, 2024 | -26.43M |
| April 08, 2024 | -27.48M |
| April 05, 2024 | -27.01M |
| April 04, 2024 | -26.90M |
| April 03, 2024 | -26.90M |
| April 02, 2024 | -27.25M |
| April 01, 2024 | -27.25M |
| March 28, 2024 | -26.90M |
| March 27, 2024 | -27.01M |
| March 26, 2024 | -27.01M |
| March 25, 2024 | -26.78M |
| March 22, 2024 | -26.78M |
| March 21, 2024 | -27.36M |
| March 20, 2024 | -27.60M |
| March 19, 2024 | -27.01M |
| March 18, 2024 | -25.62M |
| Date | Value |
|---|---|
| March 15, 2024 | -26.20M |
| March 14, 2024 | -27.25M |
| March 13, 2024 | -26.08M |
| March 12, 2024 | -25.85M |
| March 11, 2024 | -30.75M |
| March 08, 2024 | -30.94M |
| March 07, 2024 | -31.21M |
| March 06, 2024 | -30.75M |
| March 05, 2024 | -30.75M |
| March 04, 2024 | -31.12M |
| March 01, 2024 | -30.66M |
| February 29, 2024 | -30.20M |
| February 28, 2024 | -30.57M |
| February 27, 2024 | -30.38M |
| February 26, 2024 | -30.20M |
| February 23, 2024 | -30.20M |
| February 22, 2024 | -29.83M |
| February 21, 2024 | -29.65M |
| February 20, 2024 | -30.84M |
| February 16, 2024 | -31.16M |
| February 15, 2024 | -30.84M |
| February 14, 2024 | -31.39M |
| February 13, 2024 | -31.76M |
| February 12, 2024 | -31.95M |
| February 09, 2024 | -31.49M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-74.74M
Minimum
Mar 12 2020
190.96M
Maximum
Jun 17 2019
-1.949M
Average
-18.90M
Median
Jan 09 2023
Enterprise Value Benchmarks
| BioXcel Therapeutics Inc | 122.34M |
| Inotiv Inc | 471.34M |
| IGM Biosciences Inc | 60.31M |
| Humacyte Inc | 398.76M |
| Moderna Inc | 31.39B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -14.53M |
| Revenue (Quarterly) | 2.769M |
| Total Expenses (Quarterly) | 13.41M |
| EPS Diluted (Quarterly) | -1.582 |
| Profit Margin (Quarterly) | -524.9% |
| Earnings Yield | -581.2% |
| Normalized Earnings Yield | -581.20 |